These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 10901373
1. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Kikuchi R, Noguchi T, Takeno S, Kubo N, Uchida Y. Br J Cancer; 2000 Jul; 83(2):215-8. PubMed ID: 10901373 [Abstract] [Full Text] [Related]
2. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. Jones JL, Glynn P, Walker RA. J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569 [Abstract] [Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
4. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S. Cancer; 1998 Apr 01; 82(7):1359-66. PubMed ID: 9529029 [Abstract] [Full Text] [Related]
5. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer. Moser PL, Kieback DG, Hefler L, Tempfer C, Neunteufel W, Gitsch G. Anticancer Res; 1999 Apr 01; 19(5C):4391-3. PubMed ID: 10650781 [Abstract] [Full Text] [Related]
6. [Prognostic value of stromal immunolabelling by MMP-2, MT1-MMP and TIMP-2 in clinically localized prostate cancer]. Semaan M, Jovenin N, Birembaut P, Menard J, Staerman F. Prog Urol; 2005 Apr 01; 15(2):250-4. PubMed ID: 15999602 [Abstract] [Full Text] [Related]
15. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]. Zhou CY, Yao JF, Chen XD. Ai Zheng; 2002 Jul 01; 21(7):735-9. PubMed ID: 12479097 [Abstract] [Full Text] [Related]
17. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I. Mod Pathol; 2000 Sep 01; 13(9):925-33. PubMed ID: 11007031 [Abstract] [Full Text] [Related]
18. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Määttä M, Soini Y, Liakka A, Autio-Harmainen H. Clin Cancer Res; 2000 Jul 01; 6(7):2726-34. PubMed ID: 10914717 [Abstract] [Full Text] [Related]
19. [Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors]. Cai W, Song JD. Ai Zheng; 2002 Jan 01; 21(1):91-4. PubMed ID: 12500407 [Abstract] [Full Text] [Related]
20. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Pesta M, Holubec L, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R. Anticancer Res; 2005 Jan 01; 25(5):3387-91. PubMed ID: 16101153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]